- short tibia / IMPC
- abnormal bone structure / IMPC
- decreased prepulse inhibition / IMPC
- decreased mean platelet volume / IMPC
- increased grip strength / IMPC
- decreased body length / IMPC
- increased circulating alanine transaminase level / IMPC
- decreased hemoglobin content / IMPC
- decreased erythrocyte cell number / IMPC
- fibro-osseous lesion / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased bone mineral content / IMPC
- hyperplasia / IMPC
- abnormal sinus arrhythmia / IMPC
- decreased bone mineral density / IMPC
C57BL/6N-Chd2tm1.2(IMPC)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:13525 |
International strain name | C57BL/6N-Chd2tm1.2(IMPC)Wtsi/WtsiH |
Alternative name | Chd2tm1.2(IMPC)Wtsi (TCOQ) |
Strain type | Targeted Mutant Strains : Conditional mutation |
Allele/Transgene symbol | Chd2tm1.2(IMPC)Wtsi |
Gene/Transgene symbol | Chd2 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | Chd2tm1.2(IMPC)Wtsi. KO first WT function activiated by cre excision of cassette. Post flp excision |
Phenotypic information | Homozygous:data not availableHeterozygous:data not available |
Breeding history | Chimeras crossed with flp on C57BL/6N and crossed with C57BL/6N, then intercrossed |
References | None available |
Homozygous fertile | not known |
Homozygous viable | not known |
Homozygous matings required | not known |
Immunocompromised | not known |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).